臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 0
	???header.visitor??? : 52799669 ???header.onlineuser??? : 563 ???header.sponsordeclaration???

???search.scope???

???search.advance???

???search.login???

???search.administrator???

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hsu j l"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 71-80 of 130 (13 Page(s) Totally)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-03-08T06:51:51Z	Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression	Lin C.-C.; Huang Y.-K.; Cho C.-F.; Lin Y.-S.; Lo C.-C.; Kuo T.-T.; Tseng G.-C.; Cheng W.-C.; Chang W.-C.; Hsiao T.-H.; Liang-Chuan Lai; Shih J.-Y.; Liu Y.-H.; Clifford Chao K.S.; Hsu J.L.; Lee P.-C.; Sun X.; Hung M.-C.; Sher Y.-P.
臺大學術典藏	2021-01-29T03:17:24Z	A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway	Hsu J.-L.;Shih-Ping Liu;Lee C.-C.;Hsu L.-C.;Ho Y.-F.;Huang H.-S.;Guh J.-H.; Hsu J.-L.; SHIH-PING LIU; Lee C.-C.; Hsu L.-C.; Ho Y.-F.; Huang H.-S.; Guh J.-H.
臺大學術典藏	2021-01-29T03:17:21Z	A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase i	Yu C.-C.;Pan S.-L.;Chao S.-W.;Shih-Ping Liu;Hsu J.-L.;Yang Y.-C.;Li T.-K.;Huang W.-J.;Guh J.-H.; Yu C.-C.; Pan S.-L.; Chao S.-W.; SHIH-PING LIU; Hsu J.-L.; Yang Y.-C.; Li T.-K.; Huang W.-J.; Guh J.-H.
臺大學術典藏	2021-01-29T03:17:19Z	KUD773, a phenylthiazole derivative, displays anticancer activity in human hormone-refractory prostate cancers through inhibition of tubulin polymerization and anti-Aurora a activity	Yu C.-C.;Shih-Ping Liu;Hsu J.-L.;Hsu J.T.A.;Kudryavtsev K.;Guh J.-H.; Yu C.-C.; SHIH-PING LIU; Hsu J.-L.; Hsu J.T.A.; Kudryavtsev K.; Guh J.-H.
臺大學術典藏	2021-01-29T03:17:19Z	Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway	Ho C.-H.;Hsu J.-L.;Shih-Ping Liu;Hsu L.-C.;Chang W.-L.;Chao C.C.-K.;Guh J.-H.; Ho C.-H.; Hsu J.-L.; SHIH-PING LIU; Hsu L.-C.; Chang W.-L.; Chao C.C.-K.; Guh J.-H.
臺大學術典藏	2021-01-29T03:17:17Z	Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: The role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways	Leu W.-J.; Swain S.P.; Chan S.-H.; Hsu J.-L.; SHIH-PING LIU; Chan M.-L.; Yu C.-C.; Hsu L.-C.; Chou Y.-L.; Chang W.-L.; Hou D.-R.; Guh J.-H.
臺大學術典藏	2021-01-29T03:17:15Z	Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways	Chan M.-L.;Yu C.-C.;Hsu J.-L.;Leu W.-J.;Chan S.-H.;Hsu L.-C.;Shih-Ping Liu;Ivantcova P.M.;Dogan ?.;Br?Se S.;Kudryavtsev K.V.;Guh J.-H.; Chan M.-L.; Yu C.-C.; Hsu J.-L.; Leu W.-J.; Chan S.-H.; Hsu L.-C.; SHIH-PING LIU; Ivantcova P.M.; Dogan ?.; Br?se S.; Kudryavtsev K.V.; Guh J.-H.
臺大學術典藏	2021-01-29T03:17:14Z	Para-toluenesulfonamide induces anti-tumor activity through Akt-dependent and -independent mTOR/p70S6K pathway: Roles of lipid raft and cholesterol contents	Hsu J.-L.;Leu W.-J.;Hsu L.-C.;Shih-Ping Liu;Zhong N.-S.;Guh J.-H.; Hsu J.-L.; Leu W.-J.; Hsu L.-C.; SHIH-PING LIU; Zhong N.-S.; Guh J.-H.
臺大學術典藏	2021-01-29T03:17:13Z	Phosphodiesterase type 5 (PDE5) inhibitors sensitize topoisomerase II inhibitors in killing prostate cancer through PDE5-independent impairment of HR and NHEJ DNA repair systems	Chang J.-F.;Hsu J.-L.;Sheng Y.-H.;Leu W.-J.;Yu C.-C.;Chan S.-H.;Chan M.-L.;Hsu L.-C.;Shih-Ping Liu;Guh J.-H.; Chang J.-F.; Hsu J.-L.; Sheng Y.-H.; Leu W.-J.; Yu C.-C.; Chan S.-H.; Chan M.-L.; Hsu L.-C.; SHIH-PING LIU; Guh J.-H.
臺大學術典藏	2021-01-29T03:17:11Z	Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling	Hsu J.-L.; Leu W.-J.; Hsu L.-C.; Ho C.-H.; SHIH-PING LIU; Guh J.-H.

Showing items 71-80 of 130 (13 Page(s) Totally)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
View [10|25|50] records per page